In December, ZimVie announced its plans to sell its spine business to HIG Capital for $375 million. Now, the deal has been secured, and ZimVie is poised to be an exclusive dental implant company, according to a Feb. 28 news release. The sale is expected to be completed in the first half of 2024.
During the fourth quarter, ZimVie saw net sales of $113.1 million in the dental segment and $100.5 million in the spine segment — year-over-year decreases of 2.4% and 10.6%, respectively. Full year spine sales fell 9% year over year with $409.2 million, and full year dental sales fell 0.5% with $457.2 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
